insights_auto
Why is OCUL down 4.95%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
US$5.57
arrow_downward
-4.95%(-0.29) 1D
US$5.51
arrow_downward
-1.08% (-0.060)bedtimeAfter hours
Closed: ኖቬም 20, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
US$5.76
High
US$5.95
Low
US$5.54
Mkt. cap
1.23 ቢ
Avg. vol.
2.99 ሚ
Volume
2.89 ሚ
52-wk high
US$16.44
52-wk low
US$5.54
EPS
-US$1.46
Beta
1.22
Shares outstanding
220.02 ሚ
No. of employees
325
Open
US$5.76
High
US$5.95
Low
US$5.54
Mkt. cap
1.23 ቢ
Avg. vol.
2.99 ሚ
Volume
2.89 ሚ
52-wk high
US$16.44
52-wk low
US$5.54
EPS
-US$1.46
Beta
1.22
Shares outstanding
220.02 ሚ
No. of employees
325
News stories
From web sources and news partners
Yahoo! Finance Canada
·
ከ10 ሰዓቶች በፊት
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, ማሣቹሰትስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com